Versant Venture Capital VI, L.P. 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 5:35 pm Unchanged | 2023-12-31 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 11,452,014 19.100% | 0 (Unchanged) | Filing |
| 2023-02-09 4:19 pm Sale | 2022-12-31 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 11,452,014 19.400% | -914,800 (-7.40%) | Filing |
| 2022-02-10 8:39 pm Purchase | 2021-12-31 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 12,366,814 22.600% | 12,366,814 (New Position) | Filing |